Baoji Pharmaceuticals (02659) has received approval for the IND application of recombinant Urinary Trypsin Inhibitor (BJ044), marking a new era for recombinant protein drugs.

As a key strategic initiative in the field of recombinant protein drugs, this advancement not only signifies the transition of Ulinastatin, a classic clinical drug, into the recombinant era but also reflects the ongoing technological breakthroughs in China within the intersection of biopharmaceuticals and synthetic biology.

Zhitong FinanceApr 17 15:29

The revolution in transitioning from intravenous to subcutaneous administration has arrived, with KJ017 officially approved. Baoji Pharmaceuticals (02659) is becoming the 'core hub' of the large-molecule drug ecosystem.

Baoji Pharma-B (02659) has officially received approval from the National Medical Products Administration (NMPA) for its core product, recombinant human hyaluronidase for injection (brand name: Baoshuyi, project code: KJ017), marking the entry of China's first and only recombinant human hyaluronidase into the market.

Zhitong FinanceApr 16 13:36

Targeting the 'bottleneck' challenges in biopharmaceuticals, Baoji Pharmaceuticals (02659) provides a technology-driven answer for high-quality development.

Baoji Pharmaceuticals currently has 12 R&D pipelines, including 3 core pipelines, with the remaining 9 products in clinical or pre-clinical stages.

Zhitong FinanceApr 9 13:35

Hong Kong Stock Announcements | Innovusion's total shipment volume of LiDAR products in the first quarter reached approximately 181,400 units, representing a year-on-year increase of about 340%.

Grand Pharmaceutical (00512) has reached a strategic cooperation agreement with the University of Hong Kong to jointly advance the research and development of innovative drugs in the anti-infective field and promote the industrialization of research outcomes; Chalco (02600) announced an expected year-on-year increase of 50% to 58% in net profit attributable to shareholders for the first quarter.

Zhitong FinanceApr 9 09:17

HKEX Announcements Digest | Innovusion's Q1 LiDAR shipments increased more than threefold year-on-year; Poly Property Group's sales reached 11.2 billion yuan in the first three months.

①In the first quarter, RoboSense's LiDAR shipments increased more than threefold year-over-year. What is the scale? ②Poly Property Group achieved sales of 11.2 billion yuan in the first three months. What is the growth rate?

cls.cnApr 8 20:24

Trump takes action on pharmaceuticals! Import drugs face a maximum tax rate of 100%.

Trump fulfilled his threat by imposing a tariff of up to 100% on certain imported patented drugs. However, giants such as Merck and Eli Lilly and Co had already privately 'negotiated for exemptions.' Who will ultimately bear the brunt?

Golden10 DataApr 3 07:59